Home » Topics » BioWorld Science

BioWorld Science
RSS

NuclixBio and PharmAbcine enter collaborative research agreement

March 15, 2022

TSC2 blockade activates mTORC1, improves photoreceptor survival and delays vision loss in RP

March 15, 2022

LCFA-CoA inhibits NME1 and regulates cancer metastasis

March 15, 2022

Cybin IRL describes new 5-HT2 receptor agonists

March 15, 2022

Novel antibacterials synthesized at the University of Jordan

March 15, 2022

New psilocin prodrugs discovered at Compass Pathfinder

March 15, 2022

Council of Scientific and Industrial Research patents nigericin derivatives

March 15, 2022

1st Bio Therapeutics identifies new ABL/LRRK2/LRRK2 mutant/RIPK2 inhibitors

March 15, 2022

2-Benzyllawsone shown to protect mice against polymicrobial sepsis

March 15, 2022

Bright Minds' BMB-101 for Dravet syndrome completes 28-day repeat toxicity studies

March 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...